Laia Garrigós
36  results:
Search for persons X
?
 
?
4

Open-label phase II clinical trial of ketoconazole as CYP17..:

Garcia-Donas, Jesus ; Hurtado, Alicia ; Garrigos, Laia...
Clinical and Translational Oncology.  25 (2023)  7 - p. 2090-2098 , 2023
 
?
7

Trastuzumab deruxtecan in HER2-positive metastatic breast c..:

Perez, Jose ; Garrigós, Laia ; Gion, Maria...
Expert Opinion on Biological Therapy.  21 (2021)  7 - p. 811-824 , 2021
 
?
8

COVID-19 in breast cancer patients: a subanalysis of the On..:

Garrigós, Laia ; Saura, Cristina ; Martinez-Vila, Clara...
Therapeutic Advances in Medical Oncology.  13 (2021)  - p. 175883592110534 , 2021
 
?
9

Skeletal adverse effects with aromatase inhibitors in early..:

Servitja, Sonia ; Martos, Tamara ; Rodriguez Sanz, Maria...
Therapeutic Advances in Medical Oncology.  7 (2015)  5 - p. 291-296 , 2015
 
?
11

Vitamin D threshold to prevent aromatase inhibitor-related ..:

Prieto-Alhambra, Daniel ; Servitja, Sonia ; Javaid, M. Kassim...
Breast Cancer Research and Treatment.  133 (2012)  3 - p. 1159-1167 , 2012
 
?
12

Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences..:

Andrea Aran ; Gonzalo Lázaro ; Vicente Marco...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227766/full.  , 2023
 
1-15